| Jeffrey S Marrs, MD | |
|
7220 Mount Rushmore Rd, Rapid City, SD 57702-8754 | |
| (605) 341-1414 | |
| (605) 341-7062 |
| Full Name | Jeffrey S Marrs |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 27 Years |
| Location | 7220 Mount Rushmore Rd, Rapid City, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093795767 | NPI | - | NPPES |
| 200045192 | Other | MEDICARE RAILROAD PTAN | |
| 1254560001 | Other | SD | CIGNA MEDICARE |
| 7301840 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 5067 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Black Hills Surgical Hospital Llp | Rapid city, SD | Hospital |
| Monument Health Rapid City Hospital | Rapid city, SD | Hospital |
| Avera St Mary's Hospital | Pierre, SD | Hospital |
| Monument Health Custer Hospital | Custer, SD | Hospital |
| Fall River Hospital - Cah | Hot springs, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Black Hills Orthopedic And Spine Center Pc | 0648172932 | 65 |
| Black Hills Orthopedic And Spine Center Of Wyoming Pc | 4789929357 | 14 |
| Black Hills Orthopedic And Spine Center Of Wyoming Pc | 4789929357 | 14 |
News Archive
Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology will host a conference call to discuss recent corporate developments on Tuesday, June 15, 2010 at 4:30 p.m., Eastern. Eamonn P. Hobbs, the Company's President and CEO, David McDonald, CFO, and Krishna Kandarpa, MD, Chief Medical Officer, will be on hand during the call and webcast.
The human body contains more bacteria than it does cells. These bacterial communities can have a positive effect on our health, by training our immune systems and helping to metabolize the foods we eat. But they can also set us up to develop digestive disorders, skin diseases, and obesity.
Tracking individual cells within the lung as they move around and multiply has given Duke University researchers new insights into the causes of Idiopathic Pulmonary Fibrosis (IPF) a disease which can only be treated now by lung transplantation.
› Verified 1 days ago
| Entity Name | Black Hills Orthopedic And Spine Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477523678 PECOS PAC ID: 0648172932 Enrollment ID: O20040205000309 |
News Archive
Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology will host a conference call to discuss recent corporate developments on Tuesday, June 15, 2010 at 4:30 p.m., Eastern. Eamonn P. Hobbs, the Company's President and CEO, David McDonald, CFO, and Krishna Kandarpa, MD, Chief Medical Officer, will be on hand during the call and webcast.
The human body contains more bacteria than it does cells. These bacterial communities can have a positive effect on our health, by training our immune systems and helping to metabolize the foods we eat. But they can also set us up to develop digestive disorders, skin diseases, and obesity.
Tracking individual cells within the lung as they move around and multiply has given Duke University researchers new insights into the causes of Idiopathic Pulmonary Fibrosis (IPF) a disease which can only be treated now by lung transplantation.
› Verified 1 days ago
| Entity Name | Black Hills Orthopedic & Spine Center Of Wyoming Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538644679 PECOS PAC ID: 4789929357 Enrollment ID: O20191023001412 |
News Archive
Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology will host a conference call to discuss recent corporate developments on Tuesday, June 15, 2010 at 4:30 p.m., Eastern. Eamonn P. Hobbs, the Company's President and CEO, David McDonald, CFO, and Krishna Kandarpa, MD, Chief Medical Officer, will be on hand during the call and webcast.
The human body contains more bacteria than it does cells. These bacterial communities can have a positive effect on our health, by training our immune systems and helping to metabolize the foods we eat. But they can also set us up to develop digestive disorders, skin diseases, and obesity.
Tracking individual cells within the lung as they move around and multiply has given Duke University researchers new insights into the causes of Idiopathic Pulmonary Fibrosis (IPF) a disease which can only be treated now by lung transplantation.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey S Marrs, MD Po Box 6850, Rapid City, SD 57709-6850 Ph: (605) 341-1414 | Jeffrey S Marrs, MD 7220 Mount Rushmore Rd, Rapid City, SD 57702-8754 Ph: (605) 341-1414 |
News Archive
Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology will host a conference call to discuss recent corporate developments on Tuesday, June 15, 2010 at 4:30 p.m., Eastern. Eamonn P. Hobbs, the Company's President and CEO, David McDonald, CFO, and Krishna Kandarpa, MD, Chief Medical Officer, will be on hand during the call and webcast.
The human body contains more bacteria than it does cells. These bacterial communities can have a positive effect on our health, by training our immune systems and helping to metabolize the foods we eat. But they can also set us up to develop digestive disorders, skin diseases, and obesity.
Tracking individual cells within the lung as they move around and multiply has given Duke University researchers new insights into the causes of Idiopathic Pulmonary Fibrosis (IPF) a disease which can only be treated now by lung transplantation.
› Verified 1 days ago
Dr. Rachel Lynn Michael, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1635 Caregiver Cir, Rapid City, SD 57702 Phone: 605-755-6700 | |
Samuel L Mortimer, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7220 Mount Rushmore Rd, Rapid City, SD 57702 Phone: 605-341-1414 | |
Emmett Terrance Mceleney, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7220 Mount Rushmore Rd, Rapid City, SD 57702 Phone: 605-341-1414 | |
Stephen G.j. Eckrich, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 7220 S Highway 16, Rapid City, SD 57702 Phone: 605-341-1414 Fax: 605-341-7062 | |
Dr. Mark L Harlow, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7220 S Highway 16, Rapid City, SD 57702 Phone: 605-341-1414 Fax: 605-341-7062 | |
Dr. Steven Alan Maser, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1635 Caregiver Cir, Rapid City, SD 57702 Phone: 605-755-6100 |